An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases

Clinical trial NCT07174843 · RECRUITING

Trial details

NCT number: NCT07174843
Sponsor: Shanghai Cell Therapy Group Co.,Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Idiopathic Inflammatory Myopathies(IIM)Immune Thrombocytopenia(ITP)Systemic Lupus Erythematosus(SLE)

Start date: 2025-09-01
Primary completion: 2027-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.